Department of Genetics, Basurto University Hospital (OSAKIDETZA/Servicio Vasco de Salud), Bilbao, Spain.
BMC Med Genet. 2011 Jun 27;12:86. doi: 10.1186/1471-2350-12-86.
Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive genetic disease characterized by the lack of reaction to noxious stimuli and anhidrosis. It is caused by mutations in the NTRK1 gene, which encodes the high affinity tyrosine kinase receptor I for Neurotrophic Growth Factor (NGF).
We present the case of a female patient diagnosed with CIPA at the age of 8 months. The patient is currently 6 years old and her psychomotor development conforms to her age (RMN, SPECT and psychological study are in the range of normality). PCR amplification of DNA, followed by direct sequencing, was used to investigate the presence of NTRK1 gene mutations. Reverse transcriptase (RT)-PCR amplification of RNA, followed by cloning and sequencing of isolated RT-PCR products was used to characterize the effect of the mutations on NTRK1 mRNA splicing. The clinical diagnosis of CIPA was confirmed by the detection of two splice-site mutations in NTRK1, revealing that the patient was a compound heterozygote at this gene. One of these alterations, c.574+1G>A, is located at the splice donor site of intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literature, which is located at the splice acceptor site of intron 16. Each parent was confirmed to be a carrier for one of the mutations by DNA sequencing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping during NTRK1 mRNA splicing. We could confirm this prediction and, more importantly, we provide evidence that the novel c.2206-2A>G mutation also disrupts normal NTRK1 splicing, leading to the use of an alternative splice acceptor site within exon 17. As a consequence, this mutation would result in the production of a mutant NTRK1 protein with a seven aminoacid in-frame deletion in its tyrosine kinase domain.
We present the first description of a CIPA-associated NTRK1 mutation causing a short interstitial deletion in the tyrosine kinase domain of the receptor. The possible phenotypical implications of this mutation are discussed.
先天性无痛无汗症(CIPA)是一种罕见的常染色体隐性遗传疾病,其特征为对有害刺激无反应和无汗。它是由 NTRK1 基因突变引起的,该基因编码神经营养因子(NGF)的高亲和力酪氨酸激酶受体 I。
我们报告了一例 8 月龄女性 CIPA 患者。目前患者 6 岁,其精神运动发育符合年龄(磁共振成像(MRI)、单光子发射计算机断层扫描(SPECT)和心理研究均在正常范围内)。采用 DNA 的 PCR 扩增,随后进行直接测序,以调查 NTRK1 基因突变的存在。采用 RNA 的逆转录酶(RT)-PCR 扩增,随后对分离的 RT-PCR 产物进行克隆和测序,以表征突变对 NTRK1 mRNA 剪接的影响。通过检测 NTRK1 中的两个剪接位点突变,证实了 CIPA 的临床诊断,提示该患者为该基因的复合杂合子。其中一种改变,c.574+1G>A,位于 5 号内含子的剪接供体位点。我们还发现了第二个突变,c.2206-2A>G,以前未在文献中报道,位于 16 号内含子的剪接受体位点。通过 DNA 测序分析,证实每位父母均为其中一种突变的携带者。有人提出,c.574+1G>A 突变会导致 NTRK1 mRNA 剪接时外显子 5 跳过。我们可以证实这一预测,更重要的是,我们提供了证据表明,新的 c.2206-2A>G 突变也会破坏 NTRK1 的正常剪接,导致在 17 号外显子内使用替代剪接受体位点。因此,该突变会导致受体酪氨酸激酶结构域产生一个七氨基酸的框内缺失的突变 NTRK1 蛋白。
我们首次描述了一种与 CIPA 相关的 NTRK1 突变,导致受体酪氨酸激酶结构域中的短间插缺失。讨论了该突变的可能表型影响。